Aquestive Therapeutics, Inc. financial data

Symbol
AQST on Nasdaq
Location
Warren, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 478% % -12%
Quick Ratio 34% % -22%
Debt-to-equity -333% % -17%
Return On Equity 140% % 122%
Return On Assets -60% % -76%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122,003,113 shares 34%
Common Stock, Shares, Outstanding 121,658,113 shares 33%
Entity Public Float $207,300,000 USD 151%
Common Stock, Value, Issued $121,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 110,584,371 shares 21%
Weighted Average Number of Shares Outstanding, Diluted 110,584,371 shares 21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $43,397,000 USD -26%
Research and Development Expense $18,913,000 USD 3.6%
Costs and Expenses $99,188,000 USD 24%
Operating Income (Loss) $55,791,000 USD -164%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $68,993,000 USD -97%
Income Tax Expense (Benefit) $14,000 USD -114%
Net Income (Loss) Attributable to Parent $68,979,000 USD -96%
Earnings Per Share, Basic 0 USD/shares -46%
Earnings Per Share, Diluted 0 USD/shares -59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $129,063,000 USD 66%
Inventory, Net $7,884,000 USD 12%
Assets, Current $151,673,000 USD 57%
Property, Plant and Equipment, Net $3,918,000 USD 1.8%
Operating Lease, Right-of-Use Asset $4,769,000 USD -10%
Other Assets, Noncurrent $3,199,000 USD -24%
Assets $163,559,000 USD 49%
Accounts Payable, Current $10,865,000 USD 43%
Employee-related Liabilities, Current $3,694,000 USD 6.9%
Accrued Liabilities, Current $5,128,000 USD 2%
Contract with Customer, Liability, Current $1,092,000 USD 4.2%
Liabilities, Current $25,574,000 USD 69%
Long-term Debt and Lease Obligation $32,500,000 USD 18%
Contract with Customer, Liability, Noncurrent $19,663,000 USD -3%
Operating Lease, Liability, Noncurrent $4,508,000 USD -12%
Other Liabilities, Noncurrent $2,058,000 USD 1.2%
Liabilities $167,668,000 USD 7.9%
Retained Earnings (Accumulated Deficit) $415,138,000 USD -20%
Stockholders' Equity Attributable to Parent $4,109,000 USD 91%
Liabilities and Equity $163,559,000 USD 49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,400,000 USD -125%
Net Cash Provided by (Used in) Financing Activities $20,646,000 USD -75%
Net Cash Provided by (Used in) Investing Activities $135,000 USD -366%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 121,658,113 shares 33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,889,000 USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $129,063,000 USD 66%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,003,000 USD -32%
Deferred Tax Assets, Valuation Allowance $94,553,000 USD 12%
Deferred Tax Assets, Gross $95,348,000 USD 13%
Operating Lease, Liability $5,109,000 USD -8.6%
Depreciation $566,000 USD -36%
Payments to Acquire Property, Plant, and Equipment $135,000 USD 366%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $68,979,000 USD -96%
Lessee, Operating Lease, Liability, to be Paid $8,086,000 USD -14%
Property, Plant and Equipment, Gross $47,817,000 USD 1.3%
Operating Lease, Liability, Current $601,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,346,000 USD 2.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,318,000 USD 2.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,977,000 USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,180,000 USD -12%
Deferred Tax Assets, Operating Loss Carryforwards $34,689,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,180,000 USD -11%
Additional Paid in Capital $410,908,000 USD 37%
Amortization of Intangible Assets $0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $8,651,000 USD 54%
Interest Expense $9,092,000 USD 49%